VIDEO

FindCenter AddIcon

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

By Amanda Feilding — 2017

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

01:11:17 min

29:53

Dr Robin Carhart-Harris - A Unified Model of the Brain Action of Psychedelics

REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.

FindCenter AddIcon
01:20:04

Paul Stamets at the Psilocybin Summit 2020 - Psilocybin Mushrooms & Their Emergent Medicines

Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.

FindCenter AddIcon
33:09

Robert Jesse: “Psychedelics: The Uncertain Paths from Re-emergence to Renaissance”

Robert Jesse will offer a view, spanning the decade from the birth of Horizons to the present day, of the significant developments that have occurred in several areas of our field. Surely they amount to a re-emergence of psychedelics. People speak of a renaissance.

FindCenter AddIcon
47:46

Robert Jesse: Psilocybin Occasions Mystical Experiences Having Sustained Spiritual Significance

Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.

FindCenter AddIcon
37:04

Horizons 2016 | Rick Doblin, PhD, and Natalie Ginsberg: “Rescheduling MDMA—History, Present, and Future”

Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.

FindCenter AddIcon
58:39

MINDSET Lecture Series: Natalie Ginsberg, MSW

Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.

FindCenter AddIcon
01:05:36

Race and Psychedelics With Dr. Monnica T. Williams

In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.

FindCenter AddIcon
27:34

Ketamine Therapy: A Disruptive Treatment Paradigm

Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States.

FindCenter AddIcon
57:00

Researching Psychedelics and DMT with Rick Strassman

Here he describes the process of setting up a program to research the psychedelic drug, DMT, at the University of New Mexico. It took two years to obtain the required permissions, as there had been a twenty year hiatus in psychedelic research on human subjects.

FindCenter AddIcon
11:33

Taking LSD, MDMA, and DMT to Treat Mental Health

A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research